EE535 Cost-Utility Analysis of an Advanced Hybrid Closed-Loop System vs Multiple Daily Injection Therapy With Intermittently Scanned Continuous Glucose Monitoring in People With Type 1 Diabetes and Above-Target HBA1C in France
Abstract
Authors
AZ Ozdemir Saltik C Jadat P Koch MI Buompensiere J Yu S de Portu O Cohen